Fischer Medical Ventures Limited (BOM:524743)
India · Delayed Price · Currency is INR 36.20
+1.48 (4.26%)
At close: Jun 12, 2026
Fischer Medical Ventures Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 250.46 | 2,514 | 379.46 | 0.36 | 0.16 |
Cash & Short-Term Investments | 250.46 | 2,514 | 379.46 | 0.36 | 0.16 |
Cash Growth | -90.04% | 562.41% | 105894.41% | 129.49% | -65.26% |
Accounts Receivable | 2,888 | 781.9 | 228.7 | 1.71 | - |
Other Receivables | 0.92 | 1.09 | 3.95 | - | - |
Receivables | 2,889 | 782.99 | 232.65 | 1.71 | - |
Inventory | 126.63 | 91.64 | 44.76 | - | - |
Prepaid Expenses | - | 2.11 | 0.55 | - | - |
Other Current Assets | 871.43 | 262.56 | 46.65 | 0.42 | 0.34 |
Total Current Assets | 4,137 | 3,653 | 704.06 | 2.48 | 0.49 |
Property, Plant & Equipment | 293.29 | 197.15 | 124.94 | - | - |
Long-Term Investments | 1,232 | 107.72 | 12.06 | - | - |
Goodwill | 67.15 | 52.77 | 22.15 | - | - |
Long-Term Accounts Receivable | - | 182.97 | - | - | - |
Long-Term Deferred Tax Assets | 15.99 | 3.87 | - | 1.06 | 1.41 |
Other Long-Term Assets | 974.09 | 376.35 | 0 | -0 | - |
Total Assets | 6,720 | 4,574 | 863.22 | 3.54 | 1.9 |
Accounts Payable | 1,026 | 206.55 | 21.56 | 0.14 | 0.07 |
Accrued Expenses | - | 32.59 | 10.28 | 0.24 | 0.23 |
Short-Term Debt | - | 601.39 | - | - | 3.89 |
Current Portion of Long-Term Debt | 720.99 | - | - | - | - |
Current Portion of Leases | 81.21 | 80.28 | 4.26 | - | - |
Current Income Taxes Payable | - | 2.11 | 2.14 | 0.1 | 0.01 |
Current Unearned Revenue | - | 88.03 | - | - | - |
Other Current Liabilities | 752 | 7.27 | 0.09 | - | -0 |
Total Current Liabilities | 2,580 | 1,018 | 38.32 | 0.48 | 4.2 |
Long-Term Debt | 2.61 | 2.63 | - | 5.72 | - |
Long-Term Leases | 265.94 | 169.44 | 12.51 | - | - |
Long-Term Deferred Tax Liabilities | -4.49 | 3.93 | 1.24 | - | - |
Other Long-Term Liabilities | 9.89 | 0.85 | - | - | - |
Total Liabilities | 2,854 | 1,195 | 52.07 | 6.2 | 4.2 |
Common Stock | 654.52 | 638.02 | 535 | 1.72 | 1.72 |
Additional Paid-In Capital | - | 2,408 | 254.93 | 1.5 | 1.5 |
Retained Earnings | - | 29.05 | 12.5 | -5.88 | -5.52 |
Comprehensive Income & Other | 3,194 | 299.99 | 8.72 | - | - |
Total Common Equity | 3,848 | 3,375 | 811.15 | -2.66 | -2.3 |
Minority Interest | 17.8 | 3.42 | - | - | - |
Shareholders' Equity | 3,866 | 3,379 | 811.15 | -2.66 | -2.3 |
Total Liabilities & Equity | 6,720 | 4,574 | 863.22 | 3.54 | 1.9 |
Total Debt | 1,071 | 853.72 | 16.77 | 5.72 | 3.89 |
Net Cash (Debt) | -820.3 | 1,660 | 362.69 | -5.36 | -3.74 |
Net Cash Growth | - | 357.65% | - | - | - |
Net Cash Per Share | -1.18 | 3.02 | 2.14 | -3.12 | -2.17 |
Filing Date Shares Outstanding | 646.24 | 638.02 | 535 | 1.72 | 1.72 |
Total Common Shares Outstanding | 646.24 | 638.02 | 535 | 1.72 | 1.72 |
Working Capital | 1,557 | 2,635 | 665.74 | 2 | -3.71 |
Book Value Per Share | 5.95 | 5.29 | 1.52 | -1.55 | -1.33 |
Tangible Book Value | 3,781 | 3,322 | 788.99 | -2.66 | -2.3 |
Tangible Book Value Per Share | 5.85 | 5.21 | 1.47 | -1.55 | -1.33 |
Buildings | - | 75.08 | 74.84 | - | - |
Machinery | - | 80.87 | 22.23 | - | - |
Construction In Progress | - | 11.11 | - | - | - |
Leasehold Improvements | - | 0.46 | - | - | - |